US Patent Issued to UNIST (ULSAN NATIONAL INSTITUTE OF SCIENCE AND TECHNOLOGY), SMARTIN BIO on Feb. 10 for "Compounds for inhibiting neovascularization factors and use thereof" (South Korean Inventors)

ALEXANDRIA, Va., Feb. 11 -- United States Patent no. 12,545,695, issued on Feb. 10, was assigned to UNIST (ULSAN NATIONAL INSTITUTE OF SCIENCE AND TECHNOLOGY) (Ulsan, South Korea) and SMARTIN BIO INC. (Chungcheongbuk-do, South Korea).

"Compounds for inhibiting neovascularization factors and use thereof" was invented by Byoung Heon Kang (Ulsan, South Korea), So-Yeon Kim (Ulsan, South Korea), Nam Gu Yoon (Ulsan, South Korea), Changwook Lee (Ulsan, South Korea) and Dong Ho Park (Daegu, South Korea).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present specification relates to compounds for inhibiting neovascularization factors and use thereof. Furthermore, the present specification relates to methods for tr...